Pazopanib Hydrochloride CAS 635702-64-6 daahirnimo>99.0% (HPLC) Warshada API
Soo saaraha soo saaraha oo leh nadiif sare iyo tayo xasilan
Magaca Kiimikada: Pazopanib Hydrochloride
CAS: 635702-64-6
Tyrosine kinase reseptor inhibitor ee daaweynta kansarka unugyada kelyaha ee horumaray ama sarcoma unug jilicsan oo horumarsan kuwaas oo helay kiimoterabi hore.
API Tayada Sare, Wax soo saarka Ganacsiga
Magaca Kiimikada | Pazopanib Hydrochloride |
La mid ah | Pazopanib HCl;GW786034 HCl;Cod-bixiye;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide Hydrochloride |
Lambarka CAS | 635702-64-6 |
Lambarka CAT | RF-API93 |
Heerka Saamiyada | Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram |
Qaanuunka molecular | C21H23N7O2S.ClH |
Miisaanka Molecular | 473.987 |
Solubility | DMSO |
Meesha dhalaalaysa | 300.0 ~ 304.0 ℃ |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Budada Jaalle Cadaan ilaa Inyar |
Aqoonsiga | Noocyada nuugista infrared ee muunada tijaabada waxay la socotaa heerka caadiga ah |
Hadhaaga dabka | ≤0.50% |
Xumaan Shaqsiyeed Kasta | ≤0.30% |
Wadarta wasakhda | ≤1.50% |
Biraha culus | ≤10pm |
Daahirnimada / Habka Falanqaynta | ≥99.0% (HPLC) |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | API, Tyrosine kinase receptor inhibitor |
Xidhmada: Dhalo, boorsada aluminium aluminium, durbaanka kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
Pazopanib Hydrochloride (CAS 635702-64-6) waa Multi-tyrosine kinase inhibitor of vascular endothelial factor reseptor (VEGFR) -1, VEGFR-2, VEGFR-3, receptor factor koritaanka platelet-derived (PDGFR) -α iyo - β, fibroblast receptor factor (FGFR) -1 iyo -3, cytokine reseptor (Kit), interleukin-2 receptor-inducible T-cell kinase (Itk), borotiinka lymphocyte-gaar ah tyrosine kinase (Lck), iyo transmembrane glycoprotein tyrosine. kinase (cFms).In vitro, pazopanib waxay joojisay autophosphorylation-ka ligand ee VEGFR-2, Kit, iyo PDGFR-beta reseptors.In vivo, pazopanib waxay joojisay VEGF-ku-abuuray VEGFR-2 fosfooraska ee sambabada jiirka, angiogenesis ee qaabka jiirka, iyo koritaanka qaar ka mid ah burooyinka bini'aadamka xenografts ee jiirarka.Waxaa loo ansixiyay kansarka unugyada kelyaha ee Maamulka Cuntada iyo Dawooyinka ee Mareykanka 2009 waxaana lagu suuq geeyaa magaca ganacsiga Votrient ee soo saaraha daroogada, GlaxoSmithKline.Votrient waa kinase inhibitor loo tilmaamay daawaynta bukaanada qaba: 1) kansarka unugyada kelyaha oo horumaray.2) Sarcoma unug jilicsan oo horumarsan oo la siiyey daawaynta kiimiko hore.